Working to Eradicate Gynecologic Cancers

Neil S. Horowitz, MD

Assistant Professor
Harvard University
75 Francis Street
Boston, MA
USA 02115


Biographical Sketch:
I am currently an Assistant Professor in OB/GYN at Harvard Medical School and the Director of Clinical Research in the Division of Gynecologic Oncology at Brigham and Women's Hospital. My education and training in the field of gynecologic oncology is as above. I have authored or co-authored over 50 peer reviewed manuscripts, over half of which have been on the topic of ovarian cancer."

Papers:
41 - Featured Poster The impact and interaction of preoperative disease burden, complex surgery, and residual disease in patients with advanced stage ovarian cancer and the effect on on patient survival: A GOG 182 analysis 60 - Scientific Plenary Predictive model for preoperative determination of microscopic residual disease at the time of primary cytoreduction in patients with advanced-stage epithelial ovarian cancer: a Gynecologic Oncology Group (GOG) 182 analysis 68 - Featured Poster Primary debulking surgery or neoadjuvant chemotherapy: what is the optimal treatment approach for obese patients with ovarian/fallopian tube/primary peritoneal carcinoma? 170 - Poster Session A Distribution of ovarian cancer recurrence following intravenous (IV) and intraperitoneal (IP) adjuvant chemotherapy after upfront cytoreductive surgery 237 - Poster Session A Clinicopathologic benchmark for prognostic modeling of advanced epithelial ovarian cancer long-term survival: a Gynecologic Oncology Group (GOG) analysis 327 - Poster Session A Prognostic factors of lymph node involvement in endometrioid endometrial cancer: a SEER analysis 365 - Poster Session B Multiple lines of chemotherapy in recurrent epithelial ovarian cancer, are more lines better? A decision analytic model